Cormorant Asset Management, LP - Mar 7, 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role: 10%+ Owner
Signature: /s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner
Stock symbol: CRBP
Transactions as of: Mar 7, 2024
Transactions value $: $23,327,560
Form type: 4
Date filed: 3/11/2024, 05:34 PM
Previous filing: Feb 6, 2024
Next filing: Mar 18, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRBP	Common Stock	Purchase	$1.77M	+46.8K	+3.17%	$37.82	1.52M	Mar 7, 2024	See Footnote	F1, F2
transaction	CRBP	Common Stock	Purchase	$420K	+10.7K	+0.71%	$39.13	1.53M	Mar 7, 2024	See Footnote	F2, F3
transaction	CRBP	Common Stock	Purchase	$3.61M	+90.3K	+5.89%	$39.99	1.62M	Mar 7, 2024	See Footnote	F2, F4
transaction	CRBP	Common Stock	Purchase	$4.21M	+102K	+6.29%	$41.23	1.73M	Mar 7, 2024	See Footnote	F2, F5
transaction	CRBP	Common Stock	Purchase	$1.21M	+29.3K	+1.7%	$41.23	1.75M	Mar 8, 2024	See Footnote	F2, F6
transaction	CRBP	Common Stock	Purchase	$1.06M	+25K	+1.42%	$42.25	1.78M	Mar 8, 2024	See Footnote	F2, F7
transaction	CRBP	Common Stock	Purchase	$802K	+18.5K	+1.04%	$43.26	1.8M	Mar 8, 2024	See Footnote	F2, F8
transaction	CRBP	Common Stock	Purchase	$2.75M	+61.7K	+3.43%	$44.62^*	1.86M	Mar 8, 2024	See Footnote	F2, F9
transaction	CRBP	Common Stock	Purchase	$7.09M	+157K	+8.42%	$45.26^*	2.02M	Mar 8, 2024	See Footnote	F2, F10
transaction	CRBP	Common Stock	Purchase	$407K	+8.86K	+0.44%	$45.96^*	2.03M	Mar 8, 2024	See Footnote	F2, F11

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $37.53 to $38.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the "SEC"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below).
F2	Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F3	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $38.77 to $39.53 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F4	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $39.55 to $40.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F5	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $40.53 to $41.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F6	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $40.83 to $41.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F7	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $42.24 to $42.48 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F8	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $43.15 to $43.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F9	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $44.20 to $44.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F10	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $44.84 to $45.72 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
F11	Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $45.88 to $46.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.